Radovich Peter — SEC insider filings

SEC reporting owner CIK 1650131. 36 insider filings on record with FilingPulse; latest filed 2026-10-22.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-11-12 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mirum Pharmaceuticals, Inc. (MIRM)PRESIDENT AND COO30—16 legs · 66,871 sh · $3,993,83537
Rain Oncology Inc. (RAIN)Director4——9
MBX Biosciences, Inc. (MBX)Director2——1

Insider filings — Radovich Peter

FiledFormIssuerReported transactionsSource
2026-10-223MBX Biosciences, Inc. (MBX)Holdings only — no transactions reportedEDGAR
2026-10-224MBX Biosciences, Inc. (MBX)Grant/award (A): 18,200 (derivative) @ $0EDGAR
2026-06-084Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 16,988 @ $19.19 · Option exercise (M): 16,988 (derivative) @ $0EDGAR
2026-03-174Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 7,220 · Option exercise (M): 23,000 · Sale (S): 16,515 @ $91.98 · Option exercise (M): 7,220 (derivative) @ $0 · Option exercise (M): 23,000 (derivative) @ $0EDGAR
2026-03-114Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,912 @ $15.87 · Option exercise (M): 5,912 (derivative) @ $0EDGAR
2026-02-034Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 2,631 @ $103.30EDGAR
2026-01-304Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 25,120 (derivative) @ $0 · Grant/award (A): 16,280 (derivative) @ $0 · Grant/award (A): 34,500 (derivative) @ $0EDGAR
2026-01-274Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,750 · Sale (S): 3,143 @ $96.19 · Option exercise (M): 5,750 (derivative) @ $0EDGAR
2026-01-234Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 4,167 · Sale (S): 2,382 @ $93.33 · Option exercise (M): 4,167 (derivative) @ $0EDGAR
2025-03-184Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 14,440 · Sale (S): 7,879 @ $44.21 · Option exercise (M): 14,440 (derivative) @ $0EDGAR
2025-03-054Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 13,681 @ $45.57 · Sale (S): 1,169 @ $45.74EDGAR
2025-02-044Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 2,627 @ $48.22EDGAR
2025-01-274Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,750 · Sale (S): 3,177 @ $47.92 · Option exercise (M): 5,750 (derivative) @ $0EDGAR
2025-01-234Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 21,660 (derivative) @ $0EDGAR
2025-01-084Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 1,998 @ $42.82EDGAR
2024-03-254Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 4,303 @ $25.80EDGAR
2024-03-184Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 1,379 @ $20.62EDGAR
2024-02-054Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 1,790 @ $26.19EDGAR
2024-01-264Rain Oncology Inc. (RAIN)Code (U): 8,796 · Disposition to issuer (D): 13,890 (derivative) · Disposition to issuer (D): 42,596 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2024-01-254Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 17,250 (derivative) @ $0EDGAR
2024-01-094Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 1,408 @ $28.03EDGAR
2023-11-154Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 218 @ $22.29EDGAR
2023-08-114Rain Oncology Inc. (RAIN)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2023-07-054Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 1,425 @ $25.65EDGAR
2023-05-194Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 968 @ $16.92EDGAR
2023-02-024Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 14,440 @ $0 · Grant/award (A): 57,750 (derivative) @ $0EDGAR
2022-11-144Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 292 @ $17.05EDGAR
2022-08-194Rain Therapeutics Inc. (RAIN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-05-124Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 1,169 @ $13.57EDGAR
2022-01-074Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 10,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2021-11-154Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 958 @ $13.52EDGAR
2021-10-014Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 8,125 @ $0 · Sale (S): 1,364 @ $19.26EDGAR
2021-05-124Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 1,006 @ $14.62EDGAR
2021-04-274Rain Therapeutics Inc. (RAIN)Conversion (C): 8,796 · Conversion (C): 9,500 (derivative) @ $0EDGAR
2021-01-114Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2020-11-124Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 861 @ $15.27EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1650131 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs